S-1 Taiho OD Tablets T25, manufactured by Okayama Taiho Pharmaceutical, is a combination drug containing tegafur, gimeracil, and oteracil potassium, with YJ code 4229101F2057. It is standardized as 25mg x 1 tablet (equivalent to tegafur) and is an oral anticancer agent.
S-1 Taiho OD Tablets T25
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
